PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Successful Completion of Entitlement Offer, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,525 Posts.
    lightbulb Created with Sketch. 110
    Two sets of trial data to be reported in September: a P2 trial looking at disease modifying signs and an interim 08 results. We have only 17 days left in September.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.